Abstract:Introduction Many patients, especially those with Irritable Bowel Syndrome (IBS), report food intolerance; however the mechanism underlying these “functional digestive symptoms” is unknown. We assessed the role of psychological factors, mucosal immune activation and visceral sensitivity on the development of lactose intolerance (LI) after ingestion of 20g lactose in IBS patients and healthy controls (HCs) with lactase deficiency: a validated, clinical experimental model of intolerance to poorly absorbed, fermentable foods (Yang et al Clin Gastro Hep 2013 in publication). Methods IBS-D patients meeting Rome III criteria (n = 277) and age/sex matched HCs (n = 64) underwent a 20g lactose hydrogen breath test (LHBT) with measurement of hydrogen production, abdominal distention, and LI symptoms. Hospital Anxiety and Depression Score assessed psychologic state. Barostat measured rectal sensitivity. Additionally, 55 IBS-D patients and 18 HCs completed colonoscopy with colon and terminal ileum (TI) biopsies for quantification of mast cells (MCs), T lymphocytes, and enterochromaffin cells (ECC). Results Hydrogen production and distention were similar in IBS patients and HCs during LHBT; however LI symptoms were more frequent in IBS (54% vs. 28%, P < 0.001), including bloating (39% vs. 14%, P < 0.001), borborygmi (39% vs. 22%, P = 0.010), pain (31% vs. 11%, P = 0.001) and diarrhoea (29% vs. 9%, P = 0.001). IBS patients were more anxious (p < 0.001) and had higher rectal sensitivity than HCs (P = 0.001). Multivariate analysis indicated that hydrogen production increased the likelihood of bloating (OR2.2 (95%CI 1.1–4.4), P = 0.028) and borborygmi (OR12.4 (3.3–45.8), P < 0.001), but not objective distention (P = 0.673). Visceral hypersensitivity also associated with bloating (OR6.6 (1.7–25.0), P = 0.005) and total symptom score (OR3.7 (1.3–10.9, P = 0.014). A planned subanalysis showed that, compared to IBS patients with no symptoms, those with LI were more anxious (p = 0.045) and more likely to have visceral hypersensitivity (p < 0.001). In those that had colonoscopy, IBS patients with LI (25/55 (45%)) had increased MCs (p < 0.006), T-cells and ECC (both p < 0.05) in proximal colonic and TI mucosa compared to patients without LI and HCs. Multivariate analysis indicated that total LI symptom score was associated with anxiety (r = 0.519, P < 0.001), MCs in terminal ileum (r = 0.650, P < 0.001) and visceral sensitivity (r = 0.629, P < 0.001). Conclusion Gas production and sensitivity to luminal distension both contribute to digestive symptoms after lactose ingestion in patients with lactase deficiency. IBS-D patients with LI are characterised by anxiety, evidence of mucosal immune activation and visceral hypersensitivity. Disclosure of Interest None Declared

Mechanism of Hypersensitivity in the Patients with Irritable Bowel Syndrome

Study of Visceral Hypersensitivity in Irritable Bowel Syndrome.

[The Changes of Mucosal Mast Cells and Substance P in Patients with Irritable Bowel Syndrome].

Study on Mast Cells of Intestinal Mucosa in Irritable Bowel Syndrome Patients under Light and Electron Microscope

Mast Cells and Neuropeptidergic Terminals: Experimental Studies of the Mechanism of Visceral Hypersensitivity in Irritable Bowel Syndrome

Changes of Substance P, Vasoactive Intestinal Peptide and Mast Cell in Colonic Mucosa of Patients with Irritable Bowel Syndrome

Lactose Intolerance In Irritable Bowel Syndrome Patients With Diarrhoea: The Roles Of Anxiety, Activation Of The Innate Mucosal Immune System And Visceral Sensitivity

OC-035 Mechanism of Lactose Intolerance in Irritable Bowel Syndrome: Role of Anxiety, Mucosal Immunity and Visceral Hypersensitivity

The expression of vasoactive intestinal peptide and mast cells in colonic mucosa of patiens with irritable bowel syndrome

Changes of vasoactive intestinal polypeptide, calcitonin gene-related peptide and mast cell in irritable bowel syndrome

The change of visceral sensitivity to intra-rectal different temperature stimulation in patients with irritable bowel syndrome

Central and peripheral hypersensitivity in the irritable bowel syndrome

Neuropeptide-positive Fibres and Mast Cells in Irritable Bowel Syndrome

Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome

The Brain-Gut Axis Mechanism of Visceral Hypersensitivity of Rats with Irritable Bowel Syndrome

Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea

Relationship between mast cells and expressions of interleukin-2 and interferon-γ on colonic mucosa in patients with post-infective irritable bowel syndrome

Study on Spinal Evoked Potentials of Visceral Hypersensitivity in Rats with Irritable Bowel Syndrome

Expression of TRP Channels in Colonic Mucosa of IBS-D Patients and Its Correlation with the Severity of the Disease

Alterations in Focal Encephalic Function in Patients of Irritable Bowel Syndrome

A Study on Cerebral Potentials Evoked by Rectal Distension in Patients with Irritable Bowel Syndrome